Company Profile
The Genelux Difference
Genelux is a Phase 3 biopharmaceutical company developing powerful therapeutics for patients suffering from difficult-to-treat cancers. The Company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor’s sophisticated defense mechanisms.
Equiniti Trust Company LLC (EQ)
Reference: Genelux Corp.
PO Box 500
Newark, NJ 07101
Assistance Online:
https://equiniti.com/us/ast-access/individuals
Contact an EQ representative:
(800) 937-5449 or (718) 921-8124
Email EQ from the website by selecting GET HELP.